Does DINOPROSTONE Cause Maternal exposure during pregnancy? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Maternal exposure during pregnancy have been filed in association with DINOPROSTONE (CERVIDIL). This represents 6.4% of all adverse event reports for DINOPROSTONE.
46
Reports of Maternal exposure during pregnancy with DINOPROSTONE
6.4%
of all DINOPROSTONE reports
0
Deaths
25
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From DINOPROSTONE?
Of the 46 reports, 25 (54.3%) required hospitalization, and 2 (4.3%) were considered life-threatening.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DINOPROSTONE. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does DINOPROSTONE Cause?
Foetal exposure during pregnancy (67)
Uterine hyperstimulation (65)
Off label use (52)
Premature separation of placenta (48)
Postpartum haemorrhage (40)
Premature baby (40)
Drug ineffective (36)
Foetal heart rate deceleration abnormality (36)
Premature delivery (33)
Exposure during pregnancy (32)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which DINOPROSTONE Alternatives Have Lower Maternal exposure during pregnancy Risk?
DINOPROSTONE vs DINUTUXIMAB
DINOPROSTONE vs DINUTUXIMAB BETA
DINOPROSTONE vs DIOSMIN
DINOPROSTONE vs DIOSMIN\HESPERIDIN
DINOPROSTONE vs DIOVAN